Cargando…

Expression prevalence and dynamics of GPCR somatostatin receptors 2 and 3 as cancer biomarkers beyond NET: a paired immunohistochemistry approach

Somatostatin receptors are clinically validated GPCR biomarkers for diagnosis and treatment of various neuroendocrine tumors (NET). Among the five somatostatin receptors, SST2 and SST3 are associated with apoptosis and cell cycle arrest, making these receptor subtypes better differentiated targets i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oron-Herman, Mor, Kirmayer, David, Lupp, Amelie, Schulz, Stefan, Kostenich, Genady, Afargan, Michel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10682014/ https://www.ncbi.nlm.nih.gov/pubmed/38012197 http://dx.doi.org/10.1038/s41598-023-47877-0

Ejemplares similares

Pathophysiology of GPCR Homo- and Heterodimerization: Special Emphasis on Somatostatin Receptors
por: Somvanshi, Rishi K., et al.
Publicado: (2012)

Inverse expression of somatostatin and CXCR4 chemokine receptors in gastroenteropancreatic neuroendocrine neoplasms of different malignancy
por: Kaemmerer, Daniel, et al.
Publicado: (2015)

Different somatostatin and CXCR4 chemokine receptor expression in gastroenteropancreatic neuroendocrine neoplasms depending on their origin
por: Mai, Rebekka, et al.
Publicado: (2019)

Reassessment of somatostatin receptor SST4 expression in bronchopulmonary and gastroenteropancreatic neuroendocrine neoplasms using the novel rabbit monoclonal anti-human SST4 antibody 7H49L61
por: Ehms, Blanca, et al.
Publicado: (2022)

A Web Server for GPCR-GPCR Interaction Pair Prediction
por: Nemoto, Wataru, et al.
Publicado: (2022)

Evaluation of Somatostatin and CXCR4 Receptor Expression in a Large Set of Prostate Cancer Samples Using Tissue Microarrays and Well-Characterized Monoclonal Antibodies
por: Werner, Christoph, et al.
Publicado: (2020)

Comparative evaluation of somatostatin and CXCR4 receptor expression in different types of thyroid carcinoma using well-characterised monoclonal antibodies
por: Czajkowski, Max, et al.
Publicado: (2022)

Is there a clinical usefulness for radiolabeled somatostatin analogues beyond the consolidated role in NETs?
por: Cuccurullo, Vincenzo, et al.
Publicado: (2017)

Somatostatin and CXCR4 chemokine receptor expression in hepatocellular and cholangiocellular carcinomas: tumor capillaries as promising targets
por: Kaemmerer, Daniel, et al.
Publicado: (2017)

Corrigendum: A Web Server for GPCR-GPCR Interaction Pair Prediction
por: Nemoto, Wataru, et al.
Publicado: (2022)

Reassessment of SST4 Somatostatin Receptor Expression Using SST4-eGFP Knockin Mice and the Novel Rabbit Monoclonal Anti-Human SST4 Antibody 7H49L61
por: Lupp, Amelie, et al.
Publicado: (2021)

Evaluation of somatostatin, CXCR4 chemokine and endothelin A receptor expression in a large set of paragangliomas
por: Kaemmerer, Daniel, et al.
Publicado: (2017)

International Union of Basic and Clinical Pharmacology. CV. Somatostatin Receptors: Structure, Function, Ligands, and New Nomenclature
por: Günther, Thomas, et al.
Publicado: (2018)

Somatostatin receptors in normal and acromegalic somatotroph cells: the U-turn of the clinician to immunohistochemistry report – a review
por: Ionovici, Nina, et al.
Publicado: (2020)

Correlation of somatostatin receptor PET/CT imaging features and immunohistochemistry in neuroendocrine tumors of the lung: a retrospective observational study
por: Rufini, Vittoria, et al.
Publicado: (2022)

MON-288 TSH Deficiency in Patients on Somatostatin Analog for TSH-PitNET
por: Illouz, Frederic, et al.
Publicado: (2020)

GPCR kinase knockout cells reveal the impact of individual GRKs on arrestin binding and GPCR regulation
por: Drube, J., et al.
Publicado: (2022)

The G Protein-Coupled Receptor Heterodimer Network (GPCR-HetNet) and Its Hub Components
por: Borroto-Escuela, Dasiel O., et al.
Publicado: (2014)

Correction to: Correlation of somatostatin receptor PET/CT imaging features and immunohistochemistry in neuroendocrine tumors of the lung: a retrospective observational study
por: Rufini, Vittoria, et al.
Publicado: (2022)

A new immunohistochemistry prognostic score (IPS) for recurrence and survival in resected pancreatic neuroendocrine tumors (PanNET)
por: Viúdez, Antonio, et al.
Publicado: (2016)

Clinical Applications of Somatostatin Receptor (Agonist) PET Tracers beyond Neuroendocrine Tumors
por: Helgebostad, Rasmus, et al.
Publicado: (2022)

Review of Immunohistochemistry Biomarkers in Pancreatic Cancer Diagnosis
por: Luu, Tuan Trong
Publicado: (2021)

PET and PET/CT with (68)Gallium-Labeled Somatostatin Analogues in Non GEP-NETs Tumors
por: Sollini, Martina, et al.
Publicado: (2014)

SAT-LB059 NET or NOT: Physiological Uptake in Pancreatic Head on Somatostatin Receptor Based Imaging
por: Jhawar, Sakshi, et al.
Publicado: (2019)

Self-Administration of Long-Acting Somatostatin Analogues in NET Patients—Does It Affect the Clinical Outcome?
por: Sowa-Staszczak, Anna, et al.
Publicado: (2021)

Opportunities to Improve Symptom Control with Somatostatin Congeners in GEP‐NETs: A Review of Key Issues
por: Anthony, Lowell B., et al.
Publicado: (2021)

Correction: A new immunohistochemistry prognostic score (IPS) for recurrence and survival in resected pancreatic neuroendocrine tumors (PanNET)
por: Viúdez, Antonio, et al.
Publicado: (2017)

VPAC2 receptor expression in human normal and neoplastic tissues: evaluation of the novel MAB SP235
por: Schulz, Stefan, et al.
Publicado: (2015)

Administration of a CXCL12 Analog in Endotoxemia Is Associated with Anti-Inflammatory, Anti-Oxidative and Cytoprotective Effects In Vivo
por: Seemann, Semjon, et al.
Publicado: (2015)

Administration of AMD3100 in endotoxemia is associated with pro-inflammatory, pro-oxidative, and pro-apoptotic effects in vivo
por: Seemann, Semjon, et al.
Publicado: (2016)

Thermodynamics of GPCR activation
por: Zhang, Xuejun C., et al.
Publicado: (2016)

GPCR homo-oligomerization
por: Milligan, Graeme, et al.
Publicado: (2019)

Somatostatin Decorated Quantum Dots for Targeting of Somatostatin Receptors
por: Hafez Abdellatif, Ahmed Abdelfattah, et al.
Publicado: (2018)

Versatile Functions of Somatostatin and Somatostatin Receptors in the Gastrointestinal System
por: Shamsi, Bilal Haider, et al.
Publicado: (2021)

Somatostatin and Somatostatin-Containing Interneurons—From Plasticity to Pathology
por: Liguz-Lecznar, Monika, et al.
Publicado: (2022)

pdCSM-GPCR: predicting potent GPCR ligands with graph-based signatures
por: Velloso, João Paulo L, et al.
Publicado: (2021)

GPCR structural characterization by NMR spectroscopy in solution: GPCR structural characterization by NMR
por: Yang, Lingyun, et al.
Publicado: (2022)

Immunohistochemistry as an Important Tool in Biomarkers Detection and Clinical Practice
por: de Matos, Leandro Luongo, et al.
Publicado: (2010)

Immunohistochemical identification of complement peptide C5a receptor 1 (C5aR1) in non-neoplastic and neoplastic human tissues
por: Nürge, Benjamin, et al.
Publicado: (2021)

Localisation of somatostatin and somatostatin receptors in benign and malignant ovarian tumours
por: Hall, G H, et al.
Publicado: (2002)

Cannot write session to /tmp/vufind_sessions/sess_30482tntigiadnlfrlp9a4si6v